Education
About Us
Working with TipRanks
Follow Us
Enzo Biochem, Inc. (ENZB)
OTHER OTC:ENZB
ENZB Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.25 - $1.19
Previous CloseN/A
VolumeN/A
Average Volume (3M)61.29K
Market Cap
$36.59M
Enterprise Value-$8.54M
Total Cash (Recent Filing)$36.69M
Total Debt (Recent Filing)$3.00M
Price to Earnings (P/E)―
Beta1.93
Next Earnings
Oct 21, 2025EPS EstimateN/A
Last Dividend Ex-Date
Nov 15, 2024Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding52,353,000
10 Day Avg. Volume67,050
30 Day Avg. Volume61,292
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap-0.23
Enterprise Value/Revenue-0.31
Enterprise Value/Gross Profit-0.71
Enterprise Value/Ebitda1.27
Forecast
1Y Price Target
$0.50Price Target Upside-28.57% Downside
Rating ConsensusHold
Number of Analyst Covering0
Enzo Biochem News
ENZB FAQ
What was Enzo Biochem, Inc.’s price range in the past 12 months?
Enzo Biochem, Inc. lowest stock price was $0.25 and its highest was $1.19 in the past 12 months.
What is Enzo Biochem, Inc.’s market cap?
Enzo Biochem, Inc.’s market cap is $36.59M.
When is Enzo Biochem, Inc.’s upcoming earnings report date?
Enzo Biochem, Inc.’s upcoming earnings report date is Oct 21, 2025 which is in 44 days.
How were Enzo Biochem, Inc.’s earnings last quarter?
Enzo Biochem, Inc. released its earnings results on Jun 16, 2025. The company reported -$0.053 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.053.
Is Enzo Biochem, Inc. overvalued?
According to Wall Street analysts Enzo Biochem, Inc.’s price is currently Overvalued.
Does Enzo Biochem, Inc. pay dividends?
Enzo Biochem, Inc. pays a Notavailable dividend of $0.1 which represents an annual dividend yield of N/A. See more information on Enzo Biochem, Inc. dividends here
What is Enzo Biochem, Inc.’s EPS estimate?
Enzo Biochem, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Enzo Biochem, Inc. have?
Enzo Biochem, Inc. has 52,353,000 shares outstanding.
What happened to Enzo Biochem, Inc.’s price movement after its last earnings report?
Enzo Biochem, Inc. reported an EPS of -$0.053 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.263%.
Which hedge fund is a major shareholder of Enzo Biochem, Inc.?
Currently, no hedge funds are holding shares in ENZB
Enzo Biochem Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$0.50 (-28.57% Downside)
$0.50 (-28.57% Downside)
Blogger Sentiment
Bullish
ENZB Sentiment 70%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-32.88%
12-Months-Change
Fundamentals
Return on Equity
-13.95%
Trailing 12-Months
Asset Growth
-32.05%
Trailing 12-Months
Company Description
Enzo Biochem, Inc.
Enzo Biochem, Inc. is a biotechnology company based in the United States, focused on the development and commercialization of innovative diagnostic products and therapeutic solutions. The company operates in two primary segments: Clinical Laboratory Services and Bioservices. Enzo's core products include molecular diagnostic tests, genetic testing services, and research reagents, aimed at enhancing disease detection and patient care across various healthcare settings.
Technical Analysis
VolitionRX
―
Precipio
―
Biodesix
―
Intelligent Bio Solutions
―
bioAffinity Technologies, Inc.
―
Ownership Overview
11.24% Insiders
<0.01% Mutual Funds
0.05% Other Institutional Investors
100.00% Public Companies and
Individual Investors